Distribution Announcement

HKEXOct 29 20:39 · Announcements

iShares Asia Trust Semi-annual Report

HKEXAug 30 18:13 · Announcements

iShares Core MSCI Taiwan Index ETF: Semi-annual Report 2023

HKEXAug 30, 2023 18:12 · Announcements

iShares Core MSCI Taiwan Index ETF: Semi-annual Report - iShares Asia Trust

HKEXAug 30, 2022 17:39 · Announcements

Top 5 Gainers among ETFs; FL2FBFTTAIWAN (07232.HK) Surges 5.5% Topping Chart

AASTOCKSJul 13, 2022 12:30

Shanghai Fosun Pharmaceutical A shares rose more than 5% H shares rose more than 7% Guo Guangchang: Fubitai is advancing normally

Shanghai Fosun Pharmaceutical's AH shares rose in intraday trading, with Shanghai Fosun Pharmaceutical's A shares up more than 5 per cent in the afternoon and H shares up more than 7 per cent. Guo Guangchang, chairman of Fosun, replied that Fosun mRNA COVID-19 vaccine approval related work is actively promoted in accordance with normal procedures. "the clinical and examination and approval of Fubitai mRNA vaccine in China has been strongly supported and concerned by many departments, including the Joint Prevention and Control of the State Council, the State Drug Administration, the Shanghai municipal party committee and the municipal government, and related matters are being carried out normally in accordance with the procedures."

新浪港股Aug 25, 2021 13:02